Experimental Vaginal Ring Fights HIV, But Will Women Wear It?

An experimental vaginal ring that continuously releases the anti-HIV drug dapivirine has the potential to save lives.

But what's it going to do to sex lives?

That's a question researchers posed as part of the ASPIRE study, which tested the flexible silicone rings with women ages 18 to 45 living in Malawi, South Africa, Uganda and Zimbabwe. And it's a practical one, explains Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, which funded ASPIRE. The less obtrusive a form of prevention is, the easier it is to convince people to use it.

Back to news